Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/senorx) has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of SenoRx, Inc. (“SenoRx” or the “Company”) (NASDAQ:SENO) in connection with their actions in causing SenoRx to enter into a merger agreement with C. R. Bard, Inc.

Our investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by Company’s board of directors; in particular, whether the Company undertook a fair process to obtain fair consideration for all shareholders of SenoRx. For more information regarding our investigation please contact Richard A. Maniskas, Esquire toll-free: (877) 316-3218 or visit: www.rmclasslaw.com/cases/senorx.

Under the terms of the merger agreement, SenoRx shareholders will receive $11 in cash for each share that they hold at the closing of the merger.

If you own shares of SenoRx and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free: (877) 316-3218 or visit: www.rmclasslaw.com/cases/senorx. You may also email Mr. Maniskas at rmaniskas@rmclasslaw.com. For more information about class action cases in general, please visit our website: www.rmclasslaw.com.

Ryan & Maniskas, LLP is a national shareholder litigation firm. Ryan and Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.

Grafico Azioni Senorx (MM) (NASDAQ:SENO)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Senorx (MM)
Grafico Azioni Senorx (MM) (NASDAQ:SENO)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Senorx (MM)